Atlas Trials

Outcome of Patients With CBF and/or NPM1-mutated AML in First Molecular Relapse.

Clinical trial NCT04931992 · UNKNOWN

Trial details

NCT number
NCT04931992
Sponsor
University Hospital, Angers
Status
UNKNOWN
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2021-06-01
Primary completion
2021-12-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.